Steve Bryson, PhD,  science writer—

Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.

Articles by Steve Bryson

BBSome complex guides dopamine transport; may impact Parkinson’s

A complex of proteins involved in cellular trafficking, called the BBSome, plays a role in regulating the transport of dopamine, the nerve cell signaling molecule that’s deficient in Parkinson’s disease, a study reveals. “Given the significant medical impact of altered dopamine signaling in multiple neurobehavioral disorders, further studies of…

Researchers find predictors of cognitive impairments over time

Cognitive function in adults with Parkinson’s disease either remains stable or progressively declines over time, according to a four-year follow-up study that also found that early problems with several tasks related to visual processing and spatial reasoning were among predictors of eventual cognitive impairments. Among Parkinson’s patients with cognitive…

New visual technique could aid in early Parkinson’s diagnosis

A new visual diagnostic technique called Cap-QuIC has the potential to advance the early detection of neurodegenerative diseases, such as Parkinson’s disease. “The simplicity and efficiency of Cap-QuIC could lower the barriers to routine screening for neurodegenerative diseases, ultimately leading to earlier intervention and better patient outcomes,” Hye Yoon…